Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Blunt Cerebrovascular Injury: later-stage trial registry

1 of 1 indexed Blunt Cerebrovascular Injury trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Blunt Cerebrovascular Injury: 1 US clinical trial tracked, 1 recruiting.

Blunt Cerebrovascular Injury is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Loma Linda University, running 1 of these trials.

Enrollment posture brief

Registry condition blunt-cerebrovascular-injury

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Blunt Cerebrovascular In (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Blunt Cerebrovascular Injury

Blunt Cerebrovascular Injury lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Blunt Cerebrovascular Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Blunt Cerebrovascular Injury is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Blunt Cerebrovascular Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Aspirin 325Mg Tab, Aspirin 81Mg Tab Drug
1 trials

US sites by state

Facility locations filed on Blunt Cerebrovascular Injury trials. A trial with sites in several states counts in each.

California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Blunt Cerebrovascular Injury page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Blunt Cerebrovascular Injury trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Loma Linda University sponsors the most Blunt Cerebrovascular Injury trials on record, review their full trial history before evaluating a specific study. See Loma Linda University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blunt Cerebrovascular Injury condition card totals 1 registered trials; most-linked intervention Aspirin 325Mg Tab, Aspirin 81Mg Tab; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.